Korea develops microbot therapeutics delivery system for oesophageal disorders

A group of scientists at the Pohang University of Science and Technology (POSTECH) and Kyungpook National Universit...

November 5, 2021 | Friday | News
Australia announces funding worth $239M for 248 medical research projects

248 innovative research projects will receive a share of $239 million from the Morrison Government to help advance our u...

November 5, 2021 | Friday | News
New strategy shot in the arm for medical innovation at Australia

Western Australia has launched its first-ever Health and Medical Life Sciences Industry Strategy, as announced by the St...

November 3, 2021 | Wednesday | News
South Korea creates artificial intestinal model to develop new drugs

A research team at the Pohang University of Science and Technology (POSTECH) in South Korea has recently developed an in...

November 3, 2021 | Wednesday | News
Singapore assembles world’s largest and highest-resolution atlas of gastric cancer

Scientists in Singapore have assembled the world’s largest and highest-resolution atlas of gastric cancer, a leadi...

November 2, 2021 | Tuesday | News
US-China ink gene therapy research agreement for Duchenne Muscular Dystrophy

CANbridge Pharmaceuticals, Inc., a leading China-based global rare disease-focused biopharmaceutical company has entered...

November 2, 2021 | Tuesday | News
Australia uses ‘Live’ brain models to hunt for Alzheimer’s treatment

Studying tiny ‘live’ models of the human brain has helped researchers understand its ageing and find a key t...

November 2, 2021 | Tuesday | News
Australia develops bionic technology to assist people with nerve damage

A shoe insole using bionic technology to help people with nerve damage maintain their balance has been designed by Unive...

October 29, 2021 | Friday | News
Clinical trial for generalised anxiety disorder receives ethics approval in Australia

Monash University in Australia has obtained ethics approval for a world-first clinical trial investigating psilocybin-as...

October 28, 2021 | Thursday | News
Singapore creates device that uses ‘light tweezers’ to trap viruses

A team of scientists led by Nanyang Technological University, Singapore (NTU Singapore) has created a laser-powered devi...

October 27, 2021 | Wednesday | News
Japan proposes drug cocktail to stop SARS-CoV-2 infection of stem cells

A team of scientists at the Center for iPS Cell Research and Application (CiRA), Kyoto University in Japan, has sho...

October 27, 2021 | Wednesday | News
Korea builds technique to measure blood flow in brain in 'Real Time'

Cerebral blood flow (CBF), which supplies oxygen and nutrients to our brain, is a crucial indicator of brain health. Inf...

October 22, 2021 | Friday | News
Australia invests $85M to find solutions for major questions in human health

Seventeen multidisciplinary research teams will each receive $5 million in funding from the Australian government to fin...

October 22, 2021 | Friday | News
Australia boosts stem cell research with grants worth $25M

The government is boosting Australian led stem cell research through $25 million in grants, to help find and develop inn...

October 21, 2021 | Thursday | News
Korean startup D&D Pharmatech secures $51M ahead of IPO in 2022

D&D Pharmatech Inc., a South Korea-based clinical-stage biotechnology startup focused on development and commerciali...

October 20, 2021 | Wednesday | News
Combating ageing with pharmacological interventions

The increasing ageing population represents a remarked worldwide socioeconomic challenge.  Pharmacological interven...

October 19, 2021 | Tuesday | Opinion
Singapore performs first-in-man trial for vision repair using regenerative therapy

With the advent of induced pluripotent stem cell (iPSC) and embryonic stem cell (ESC) technology, regenerative stem cell...

October 19, 2021 | Tuesday | News
World's first long-acting herpes treatment trial taking place in US, China

Shanghai Public Health Clinical Centre and Cheng Kung University's Department of Microbiology and Immunology have joined...

October 19, 2021 | Tuesday | News